Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).

scientific article published on 04 October 2013

Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1019814579
P356DOI10.1136/ANNRHEUMDIS-2013-204223
P8608Fatcat IDrelease_mn27ubbqqbayneqn3uvgicpwm4
P932PMC publication ID3888623
P698PubMed publication ID24095940
P5875ResearchGate publication ID257462864

P50authorPaul EmeryQ19859634
Helga RadnerQ88548670
Emilio Martin-MolaQ88996849
Kevin L WinthropQ90243645
Najia Hajjaj-HassouniQ39410823
Iain McInnesQ41687181
Maya Hema BuchQ44940582
Jonathan KayQ45733563
Jacqueline DetertQ47262425
Alejandro BalsaQ57028851
Martin SoubrierQ58884902
Maxime DougadosQ63136268
Josef S SmolenQ66753681
P2093author name stringYeong-Wook Song
Shue-Fen Luo
Masayoshi Harigai
Peter Balint
Carlo Maurizio Montecucco
Gustavo Casado
Jacqueline Detert
Gabriel Maciel
Bassel El-Zorkany
Reka Kurucz
Anna Antunez
Harald Erwin Vonkeman
P2860cites workThe american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisQ27860872
Cardiovascular care and cancer screening in female nurses with and without rheumatoid arthritisQ28168900
An audit of influenza and pneumococcal vaccination in rheumatology outpatientsQ33289919
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritisQ33505914
Why do people with rheumatoid arthritis still die prematurely?Q33697879
Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokersQ33706159
Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis registerQ73574433
Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problemQ79918765
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of CardiologyQ33740111
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severityQ34238357
The mortality of rheumatoid arthritisQ34338843
Interaction between smoking and HLA-DRB1*04 gene is associated with a high cardiovascular risk in Brazilian Amazon patients with rheumatoid arthritisQ34388610
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE projectQ34534248
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studiesQ34889152
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.Q34986307
Nurse-led disease management for hypertension control in a diverse urban community: a randomized trialQ35980636
Impact of age at smoking initiation, dosage, and time since quitting on cardiovascular disease in african americans and whites: the atherosclerosis risk in communities studyQ36077038
No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general populationQ36291405
Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritisQ36464352
Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA studyQ36757060
Orthopedic surgery among patients with rheumatoid arthritis 1980-2007: a population-based study focused on surgery rates, sex, and mortalityQ36789999
Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysisQ36907729
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature researchQ37342445
Evidence for treating rheumatoid arthritis to target: results of a systematic literature searchQ37710906
High prevalence of the B2+C2 subgenotype mixture in patients with chronic hepatitis B in Eastern ChinaQ37728704
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseasesQ37816066
EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritisQ37950992
Co-morbidities in established rheumatoid arthritis.Q37964309
Impact of hepatitis B vaccination among children in Guangdong Province, ChinaQ38026237
Malignancy as a comorbidity in rheumatic diseasesQ38029322
The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatmentQ38063474
Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection.Q38856012
Occult hepatitis B virus infection in a cohort of Egyptian chronic hemodialysis patients.Q38991185
Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town.Q39542487
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analysesQ43636113
Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registryQ43736535
The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort studyQ45792532
Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients.Q51211966
Development of a disease activity score based on judgment in clinical practice by rheumatologists.Q52399756
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectrheumatoid arthritisQ187255
comorbidityQ1414874
P1104number of pages7
P304page(s)62-68
P577publication date2013-10-04
P1433published inAnnals of the Rheumatic DiseasesQ4767876
P1476titlePrevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).
P478volume73

Reverse relations

cites work (P2860)
Q37696434"You Obviously Just Have to Put on a Brave Face": A Qualitative Study of the Experiences and Coping Styles of Men With Rheumatoid Arthritis
Q40035636'The lesser of two evils…' - views of persons with rheumatoid arthritis on medication adherence: a qualitative study.
Q36963507A Multifaceted Intervention to Improve Influenza, Pneumococcal, and Herpes Zoster Vaccination among Patients with Rheumatoid Arthritis
Q58794686An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome‑protamine-DNA-siRNA complex with cell permeable peptides
Q64060558An integrative transcriptome analysis framework for drug efficacy and similarity reveals drug-specific signatures of anti-TNF treatment in a mouse model of inflammatory polyarthritis
Q54936252Association between Rheumatoid Arthritis and Respiratory Allergic Diseases in Korean Adults: A Propensity Score Matched Case-Control Study.
Q40216184Association of Somatic Comorbidities and Comorbid Depression With Mortality in Patients With Rheumatoid Arthritis: A 14-Year Prospective Cohort Study
Q30234766Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma
Q90153398Attitudes towards Oral Health in Patients with Rheumatoid Arthritis: A Qualitative Study Nested within a Randomized Controlled Trial
Q58621582Balancing benefits and risks of glucocorticoids in rheumatic diseases and other inflammatory joint disorders: new insights from emerging data. An expert consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and O
Q26864064Best practices for cardiovascular disease prevention in rheumatoid arthritis: a systematic review of guideline recommendations and quality indicators
Q92737108Burden of rheumatoid arthritis among US Medicare population: co-morbidities, health-care resource utilization and costs
Q90602641COVID-19 infection and rheumatoid arthritis: Faraway, so close!
Q91776881Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions
Q35891702Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid Arthritis
Q92464675Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment
Q38568465Cardiovascular comorbidity in rheumatic diseases
Q90629334Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study
Q90673384Cardiovascular risk factors' behavior during the early stages of the disease, in Hispanic rheumatoid arthritis patients: a cohort study
Q26744334Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps
Q97517449Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A review
Q35224179Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years
Q45796102Chinese Registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis
Q47320087Chronic disease list conditions in patients with rheumatoid arthritis in the private healthcare sector of South Africa.
Q91909930Chronic obstructive pulmonary disease and rheumatic diseases: A systematic review on a neglected comorbidity
Q38262835Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment
Q91750406Chronic obstructive pulmonary disease in rheumatoid arthritis: a systematic review and meta-analysis
Q52624368Clinical characteristics and patient-reported outcomes in patients with inadequately controlled rheumatoid arthritis despite ongoing treatment.
Q44807577Clinical guidelines: Addressing comorbidities in systemic inflammatory disorders
Q38615462Co-morbidity index in rheumatoid arthritis: time to think
Q40354684Coexistent malignant conditions in rheumatoid arthritis - A population-based cross-sectional study
Q60912319Common mechanisms and holistic care in atherosclerosis and osteoporosis
Q55497929Comorbid TNF-mediated heart valve disease and chronic polyarthritis share common mesenchymal cell-mediated aetiopathogenesis.
Q39829013Comorbid conditions are associated with healthcare utilization, medical charges and mortality of patients with rheumatoid arthritis
Q42680293Comorbidities and health-related quality of life in Koreans with knee osteoarthritis: Data from the Korean National Health and Nutrition Examination Survey (KNHANES).
Q45826937Comorbidities in a Mexican mestizo cohort with established rheumatoid arthritis.
Q92570415Comorbidities in inflammatory bowel disease: a call for action
Q41588352Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis.
Q58779794Comorbidities in rheumatic arthritis
Q33579891Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey
Q36471067Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis
Q38990549Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis.
Q36220832Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study.
Q39146167Complementary and Alternative Medicine Use in Rheumatoid Arthritis: Considerations for the Pharmacological Management of Elderly Patients.
Q26765282Costs associated with rheumatoid arthritis in Italy: past, present, and future
Q61812081Cotreatment with methotrexate in routine care patients with rheumatoid arthritis receiving biological treatment yields better outcomes over time
Q35470652Current and future trends in biomarker discovery and development of companion diagnostics for arthritis.
Q48056228Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study.
Q92060736Determining Rheumatology Patient Interest in a Group Strength Training Program - Results of an Exercise Survey
Q36593810Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process
Q35985497Different Risk of Tuberculosis and Efficacy of Isoniazid Prophylaxis in Rheumatoid Arthritis Patients with Biologic Therapy: A Nationwide Retrospective Cohort Study in Taiwan
Q54984291Disease Characteristics and Change in Arthritis Activity according to Treatment in Hepatitis B Surface Antigen-positive Rheumatoid Arthritis Patients: a Retrospective Chart Review Study.
Q57163056Disease and management beliefs of elderly patients with rheumatoid arthritis and comorbidity: a qualitative study
Q91972505Does periodontitis represent a risk factor for rheumatoid arthritis? A systematic review and meta-analysis
Q91663787Dose-response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case-control study
Q64068266Drug-related problems in patients with rheumatoid arthritis
Q39027986Economic Burden of Rheumatoid Arthritis in Italy: Possible Consequences on Anti-Citrullinated Protein Antibody-Positive Patients.
Q47552171Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
Q92176543Efficacy and safety data based on historical or pre-existing conditions at baseline for patients with active rheumatoid arthritis who were treated with baricitinib
Q40687578Efficacy of a Rheumatoid Arthritis-Specific Smoking Cessation Program: A Randomized Controlled Pilot Trial
Q45875046Engineering Specificity and Function of Therapeutic Regulatory T Cells.
Q60300869Epidemiology and treatment patterns of rheumatoid arthritis in a large cohort of Arab patients
Q52602682Estimating the response and economic burden of rheumatoid arthritis patients treated with biologic disease-modifying antirheumatic drugs in Taiwan using the National Health Insurance Research Database (NHIRD).
Q33800700Evaluation of Vitamin D Status in Rheumatoid Arthritis and Its Association with Disease Activity across 15 Countries: "The COMORA Study".
Q61809484Evaluation of alexithymia in patients affected by rheumatoid arthritis and psoriatic arthritis: A cross-sectional study
Q35654020Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial
Q47944378Examining the Relationship Between Pain Catastrophizing and Suicide Risk in Patients with Rheumatic Disease: the Mediating Role of Depression, Perceived Social Support, and Perceived Burdensomeness
Q31153194Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry.
Q91584436Fasting triglycerides and glucose index: a useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosus
Q57299625Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project
Q88455843Frequency and Predictors of Communication About High Blood Pressure in Rheumatoid Arthritis Visits
Q31149663Gender-associated comorbidities in rheumatoid arthritis and their impact on outcome: data from GENIRA.
Q55000662Genes responding to Canakinumab therapy in SJIA are -inversely - disregulated in adult onset Still's disease.
Q30238991Healthcare burden of depression in adults with arthritis
Q40212689High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database.
Q47625199High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data
Q92278043Household air pollution and arthritis in low-and middle-income countries: Cross-sectional evidence from the World Health Organization's study on Global Ageing and Adult Health
Q64247492IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study
Q36005210Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).
Q38844078Implementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis.
Q40195611In rheumatoid arthritis, country of residence has an important influence on fatigue: results from the multinational COMORA study
Q39371950In wealthier countries, patients perceive worse impact of the disease although they have lower objectively assessed disease activity: results from the cross-sectional COMORA study
Q46337002Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis
Q64231412Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study
Q92703340Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment-A Systematic Literature Review
Q41507083Indirect costs associated with early exit from work attributable to rheumatic diseases
Q35813953Inhibition on JAK-STAT3 Signaling Transduction Cascade Is Taken by Bioactive Peptide Alpha-S2 Casein Protein from Goat Ethawah Breed Milk
Q55279319Is the serum oxytocin level altered by treatment in rheumatoid arthritis patients complicated with depression?
Q42134953Large country differences in work outcomes in patients with RA - an analysis in the multinational study COMORA.
Q38554197Lipid and Metabolic Changes in Rheumatoid Arthritis.
Q58567872Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment
Q30888876Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort
Q39371943Lower education and living in countries with lower wealth are associated with higher disease activity in rheumatoid arthritis: results from the multinational COMORA study
Q99202798Managing rheumatoid arthritis during COVID-19
Q55018553Mesenchymal TNFR2 promotes the development of polyarthritis and comorbid heart valve stenosis.
Q36633607Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis B.
Q37243485Methotrexate is not associated with increased liver cirrhosis in a population-based cohort of rheumatoid arthritis patients with chronic hepatitis C.
Q43199986Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
Q35393861Mining disease risk patterns from nationwide clinical databases for the assessment of early rheumatoid arthritis risk
Q38908843Modeling quality of life in patients with rheumatic diseases: the role of pain catastrophizing, fear-avoidance beliefs, physical disability, and depression
Q90415257Multicenter Cross-sectional Study of Patients with Rheumatoid Arthritis in Greece: Results from a cohort of 2.491 patients
Q28070338Multimorbidity in rheumatic conditions
Q47692825Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis
Q64271473New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib
Q64951770New insights into the prevalence of depressive symptoms and depression in rheumatoid arthritis - Implications from the prospective multicenter VADERA II study.
Q38634276Novel approaches to biological therapy for psoriatic arthritis
Q39371685Novel treatment strategies in rheumatoid arthritis.
Q35633961Online training on skin cancer diagnosis in rheumatologists: results from a nationwide randomized web-based survey
Q37021279Openness to and preference for attributes of biologic therapy prior to initiation among patients with rheumatoid arthritis: patient and rheumatologist perspectives and implications for decision making
Q41026313Parental rheumatoid arthritis and long-term child morbidity: a nationwide cohort study
Q28603520Patient Perspectives on Sharing Anonymized Personal Health Data Using a Digital System for Dynamic Consent and Research Feedback: A Qualitative Study
Q60928282Periodontal pathogens and the association between periodontitis and rheumatoid arthritis in Korean adults
Q37242610Periodontitis is associated with rheumatoid arthritis: a study with longstanding rheumatoid arthritis patients in Korea
Q50047407Perioperative Inpatient Use of Selective Serotonin Reuptake Inhibitors Is Associated With a Reduced Risk of THA and TKA Revision.
Q89996621Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis
Q47674117Pilot Study of Metabolomics and Psychoneurological Symptoms in Women With Early Stage Breast Cancer
Q38777496Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative
Q59813359Positive predictive value of first-time rheumatoid arthritis diagnoses and their serological subtypes in the Danish National Patient Registry
Q41168364Power of national economy, disease control and employment status in patients with RA-an analytical multi-site ecological study
Q64996337Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study.
Q94591396Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study
Q97532363Prevalence of Malignancy Among Urban Black Rheumatoid Arthritis Patients
Q37206056Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study.
Q40307261Prevalence of co-morbidities and evaluation of their monitoring in Korean patients with rheumatoid arthritis: comparison with the results of an international, cross-sectional study (COMORA).
Q40405924Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study
Q38691780Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis
Q59793023Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative, multicenter, matched-cohort study
Q50002598Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg
Q40830395Prevention of HBV reactivation in patients treated with biologic agents.
Q39082330Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada.
Q90454106Prognostic value of comorbidity indices and lung diseases in early rheumatoid arthritis: a UK population-based study
Q26744032Psoriasis, psoriatic arthritis, and rheumatoid arthritis: Is all inflammation the same?
Q90608529Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
Q60954470Reasons to stop drinking alcohol among patients with rheumatoid arthritis in Sweden: a mixed-methods study
Q64259679Response to: "A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post hoc results from the certolizumab pegol phase 4 PREDICT trial"
Q90117853Rheumatoid arthritis and neurodegenerative dementia: a nested case-control study and a follow-up study using a national sample cohort
Q52578723Rheumatoid arthritis is associated with increased in-hospital mortality in asthma exacerbations: a nationwide study.
Q47552951Rheumatoid arthritis: A single-center Egyptian experience.
Q35896998Risk for Mycobacterial Disease among Patients with Rheumatoid Arthritis, Taiwan, 2001-2011.
Q90415221Rituximab and lenalidomide combination treatment for rheumatoid arthritis complicated with myelodysplastic syndrome: A case report
Q55341968Safety, Effectiveness, and Treatment Persistence of Golimumab in Elderly Patients with Rheumatoid Arthritis in Real-World Clinical Practice in Japan.
Q58735831Sarilumab: patient-reported outcomes in rheumatoid arthritis
Q91641942Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients
Q39665336Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort.
Q40807740Serious infections in patients with rheumatoid arthritis
Q35792901Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial
Q35970365Sex Differences in the Effects of a Biological Drug for Rheumatoid Arthritis on Depressive State
Q40065441Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
Q47671088Sex, Symptom Severity, and Quality of Life in Rheumatology
Q52622829Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity: Single center real life results.
Q90133923Study of vertebral fracture and Scanographic Bone Attenuation Coefficient in rheumatoid arthritis and ankylosing spondylitis vs. controls
Q47110507Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
Q39242725Tackling comorbidity associated with rheumatic diseases in standard practice
Q60959818Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality?
Q58803289The INCLUDE study: INtegrating and improving Care for patients with infLammatory rheUmatological DisordErs in the community; identifying multimorbidity: Protocol for a pilot randomized controlled trial
Q89860622The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review
Q47101018The Relationship between the Serum Oxytocin Levels, Disease Activity, the ADLs and the QOL in Patients with Rheumatoid Arthritis
Q36187856The Scottish Early Rheumatoid Arthritis (SERA) Study: an inception cohort and biobank
Q61797300The Use of Rheumatic Disease Comorbidity Index for Predicting Clinical Response and Retention Rate in a Cohort of Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Alpha Inhibitors
Q90434053The association between 10-year fracture risk by FRAX and osteoporotic fractures with disease activity in patients with rheumatoid arthritis
Q90494559The association between Bell's palsy and rheumatoid arthritis: A longitudinal study
Q48075422The burden of disease in rheumatoid arthritis
Q36000249The challenging interplay between rheumatoid arthritis, ageing and comorbidities
Q31151686The clinical status and economic savings associated with remission among patients with rheumatoid arthritis: leveraging linked registry and claims data for synergistic insights
Q39638950The correlations of socioeconomic status, disease activity, quality of life, and depression/anxiety in Chinese patients with rheumatoid arthritis
Q38671481The dynamic evolution of rheumatology in Korea
Q36761926The effect of tofacitinib on pneumococcal and influenza vaccine responses in rheumatoid arthritis
Q64984148The impact of different rheumatic diseases on health-related quality of life: a comparison with a selected sample of healthy individuals using SF-36 questionnaire, EQ-5D and SF-6D utility values.
Q36895220The influence of lifestyle habits on quality of life in patients with established rheumatoid arthritis-A constant balancing between ideality and reality
Q88795124The influence of thyroid diseases, diabetes mellitus, primary hyperparathyroidism, vitamin B12 deficiency and other comorbid autoimmune diseases on treatment outcome in patients with rheumatoid arthritis: An exploratory cohort study
Q92308481The physiological significance of the circadian dynamics of the HPA axis: Interplay between circadian rhythms, allostasis and stress resilience
Q57972405The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: results from the UK Biobank
Q40125487The psychosocial status of the family members of rheumatoid arthritis patients in Korea
Q89830820The risk of deliberate self-harm following a diagnosis of rheumatoid arthritis or ankylosing spondylitis: A population-based cohort study
Q52654900The role of lymphotoxin-α in rheumatoid arthritis.
Q47097488Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP): An observational cohort study
Q54965764Tools for the Assessment of Comorbidity Burden in Rheumatoid Arthritis.
Q40492165Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting
Q36300479Treatment of rheumatoid arthritis by molecular-targeted agents: efficacy and limitations
Q57169964Treatment patterns, health care resource utilization and costs of rheumatoid arthritis patients in Italy: findings from a retrospective administrative database analysis
Q93061961Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe
Q55405093Trends in hip fracture in patients with rheumatoid arthritis: results from the Spanish National Inpatient Registry over a 17-year period (1999-2015). TREND-AR study.
Q34394394Use of the painDETECT tool in rheumatoid arthritis suggests neuropathic and sensitization components in pain reporting.
Q35045933Utility of different cardiovascular disease prediction models in rheumatoid arthritis
Q48046623Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge
Q28074148What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?
Q46745289When treating rheumatoid arthritis be vigilant for influenza (& pneumonia): Don't ignore, don't neglect
Q40603508Which Factors Influence Self-Efficacy in Patients with Chronic Inflammatory Polyarthritis?
Q52839369[Choosing wisely recommendations in rheumatology : One year after their first publication].
Q87510837[Collation of comorbidities: core competence of internist rheumatologists]
Q90258576[Depressive symptoms in early rheumatoid arthritis : Within the rheumatism network ADAPTHERA]
Q52876178[Gender-specific differences in comorbidities of rheumatoid arthritis].
Q90235204[Higher prevalence of depressive and anxiety symptoms in early arthritis patients in comparison to the normal population]
Q52878034[Safety of antirheumatic drug treatment in the elderly].
Q52850236[Standardized outcome parameters].
Q87387286[Treatment of cardiovascular risk factors]
Q87320426[Which kind of structures and facilities are needed for the care of elderly patients with rheumatic diseases?]

Search more.